TLR7 and cancer: We therefore tested whether recombinant IFN-β could synergize with two other TLR agonists, Pam3CSK4 (TLR1/2) and CL264 (TLR7) in inducing NO production and macrophage-mediated cancer cell growth inhibition by BMDMs.